Global Anti-Snoring Devices Market - Focused Insights 2025-2030

ANTI-SNORING DEVICES MARKET INSIGHTS

The global anti-snoring devices market, valued at USD 1.42 billion in 2024, is projected to reach USD 2.28 billion by 2030, growing at an 8.20% CAGR. The market is highly competitive, with national, regional, and global players. Growth is driven by technological advancements, a rising aging population with sleep apnea, and increasing obesity rates.

MARKET TRENDS & DRIVERS

Transition to Smart, Adaptive, and Contact-Free Devices

Modern anti-snoring mouthpieces now feature adjustable jaw positioning, advanced materials, and high-tech sensors to monitor snoring intensity. Smart anti-snoring devices with Bluetooth connectivity allow users to track sleep patterns via smartphone apps. The industry is also shifting toward contact-free solutions, with innovations like Smart Nora’s high-tech, non-invasive device that reduces snoring and detects its root cause, marking a significant advancement in the market.

Increasing Demand for Home-Based Devices

The demand for air anti-snoring devices is rising, driven by the growing popularity of home-based sleep solutions. As people prioritize sleep health, they seek non-invasive, cost-effective alternatives to medical treatments for snoring. Technological advancements have made these devices more affordable, effective, and user-friendly. Smart data-driven solutions further enhance their appeal by allowing users to monitor and analyze sleep patterns from the comfort of their homes, fueling market growth.

Broadening Use of Anti-Snoring Devices in Health and Wellness

The demand for anti-snoring devices has expanded beyond personal use, gaining traction in clinical settings, rehabilitation centers, and corporate wellness programs. Organizations recognize the link between sleep quality, cognitive function, and productivity, driving adoption. Sleep clinics and medical institutions use these devices as non-invasive treatments for mild to moderate obstructive sleep apnea (OSA) and chronic snoring. Additionally, rehabilitation centers increasingly incorporate them for post-surgical recovery and managing sleep-related conditions like cardiovascular and metabolic disorders.

ANTI-SNORING DEVICES MARKET HIGHLIGHTS

• By Product: In 2024, the oral devices segment led the anti-snoring devices market with over 46% share. These non-surgical solutions for obstructive sleep apnea (OSA) and snoring are widely recognized for their safety and effectiveness. Technological advancements, including mandibular advancement devices (MADs) and tongue-retaining devices (TRDs), have boosted adoption. Offering comfort, ease of use, and proven results, oral devices work by repositioning the jaw or tongue to prevent airway obstruction, making them a preferred choice for snoring reduction.
• By Age Group: The below-40 age group segment is expected to grow by USD 164.81 million during the forecast period. While sleep apnea is more common in older adults, its prevalence among younger individuals is rising due to increasing obesity rates and lifestyle factors. With a growing working population and heightened awareness of sleep health, the demand for anti-snoring devices is expanding in this age group, driving market growth.
• By Consumer: The men segment holds the largest share in the global anti-snoring devices market. While both genders experience snoring and sleep apnea, habitual snoring is more common in men (40%) than women (25%). This is due to anatomical factors like larger airways and fat distribution around the neck, increasing airway obstruction risk. Higher obesity rates, chronic diseases, a large working population, and unhealthy lifestyle habits further contribute to the growing demand for anti-snoring devices among men.
• By End-Users: The sleep labs/dental clinics segment leads the global anti-snoring devices market. Sleep labs diagnose sleep disorders like obstructive sleep apnea (OSA) and use anti-snoring devices for assessment and treatment. Medical professionals prescribe solutions such as CPAP therapy, Mandibular Advancement Devices (MADs), and positional therapy aids based on diagnostic findings. The rising number of sleep labs worldwide is boosting demand for these devices. Additionally, dental clinics play a key role in offering oral appliances like MADs for OSA treatment, further driving market growth.

GEOGRAPHICAL ANALYSIS

North America leads the global anti-snoring devices market with over 32% share, driven by a high prevalence of sleep apnea and growing demand for effective solutions. The U.S. dominates the region, with over 30 million people diagnosed with sleep apnea in 2024, according to the American Academy of Sleep Medicine. Increasing awareness, technological advancements, and the availability of wearable, user-friendly devices are fueling market growth. Untreated sleep apnea poses risks such as heart disease, depression, and diabetes, further driving demand for anti-snoring solutions.

COMPETITIVE LANDSCAPE

The global anti-snoring devices market report features exclusive data on 29 vendors, with key players including Apnea Sciences, Fisher & Paykel Healthcare, Koninklijke Philips, ResMed, and Tomed. These companies offer high-quality, comfortable solutions that meet consumer needs and international standards. Leading vendors are enhancing product efficiency, expanding their reach, and strengthening market positions through strategies like product launches, advanced material innovations, and acquisitions. These efforts have intensified competition and helped them capture a larger market share.

RECENT VENDORS ACTIVITIES

• In 2023, Resmed acquired Somnoware which was one of the leading companies in digital sleep solutions. This acquisition will support the company to strengthen its anti-snoring devices portfolio.
• In 2024, Fisher & Paykel Healthcare launched of Nova Micro Nasal Pillows Mask to treat OSA in the US.